Prenetics will explore digital asset adoption and Bitcoin financial strategies

ChainCatcher news, Nasdaq-listed company Prenetics announced the transfer of its ownership in ACT Genomics Holdings Company Limited to Delta Electronics, Inc. for $71.78 million, bringing the company's cash reserves to approximately $86 million, with expected cash and short-term assets of $117 million. The company maintains a zero-debt balance sheet, allowing it to explore other financial management options, including digital asset adoption and Bitcoin financial strategies.